Nutrition Course, School of Medicine, Federal University of Rio Grande do Sul-UFRGS, Porto Alegre, Rio Grande do Sul, Brazil.
J Ren Nutr. 2012 Jul;22(4):440-9. doi: 10.1053/j.jrn.2011.09.003. Epub 2011 Nov 4.
To evaluate leptin, insulin resistance (IR), and changes in body composition and lipid profile within 5 years after renal transplantation.
Longitudinal study.
Hospital de Clínicas de Porto Alegre/RS, Brazil.
Thirty-two renal transplant recipients were followed up for 5 years after transplantation.
Data were collected at transplantation time (T₁) and after 3 months (T₂), 1 year (T₃), and 5 years (T₄). Leptin serum levels, IR assessed by homeostasis model assessment (HOMA) index, lipid profile, and anthropometric measurements were analyzed. Data were compared with a control group at baseline.
At T₁, pretransplant patients had leptin levels (ng/mL) (11.9 [9.2 to 25.2]) higher than the control group (7.7 [5.2 to 9.9]; P < .0001). After transplantation, levels decreased at T₂ and T₃, but increased at T₄ to values similar to those seen at T₁ (T₄: 9.2 [5.7 to 21]; P = 1). HOMA also decreased at T₂, but increased at T₄ to identical levels (T₁: 2.1 [1.63 to 2.23], T₄: 2.1 [1.6 to 2.85]; P = 1). No significant changes in body fat percentage (BF%) were observed; however, the arm muscle circumference increased significantly at T₄ (P < .0001). At T₂, total cholesterol, triglycerides, and low-density lipoprotein cholesterol increased, whereas at T₄, lipid profile moved toward T₁ levels. By linear regression analysis, gender, BF%, and HOMA were independent predictors of leptin levels. A trend toward higher body mass index was observed in woman who also presented higher leptin and lower HOMA levels.
Leptin levels and HOMA decrease in the immediate posttransplant period and remain reduced for at least 1 year. Five years post transplantation, leptin, IR, BF%, and lipids have a profile similar to those in the pretransplant period. This metabolic profile is possibly associated with the elevated incidence of cardiovascular diseases observed in the late posttransplant period.
评估肾移植后 5 年内瘦素、胰岛素抵抗(IR)以及身体成分和脂质谱的变化。
纵向研究。
巴西阿雷格里港临床医院。
32 名肾移植受者在移植后随访 5 年。
在移植时(T₁)以及 3 个月(T₂)、1 年(T₃)和 5 年(T₄)时收集数据。分析血清瘦素水平、通过稳态模型评估(HOMA)指数评估的 IR、脂质谱和人体测量学测量值。将数据与基线时的对照组进行比较。
T₁时,移植前患者的瘦素水平(ng/mL)(11.9 [9.2 至 25.2])高于对照组(7.7 [5.2 至 9.9];P <.0001)。移植后,T₂和 T₃时水平下降,但 T₄时升高至与 T₁时相似的值(T₄:9.2 [5.7 至 21];P = 1)。HOMA 在 T₂时也降低,但在 T₄时升高至相同水平(T₁:2.1 [1.63 至 2.23],T₄:2.1 [1.6 至 2.85];P = 1)。体脂百分比(BF%)没有显著变化;然而,T₄ 时臂肌围明显增加(P <.0001)。T₂ 时,总胆固醇、甘油三酯和低密度脂蛋白胆固醇升高,而 T₄ 时,脂质谱向 T₁ 水平移动。通过线性回归分析,性别、BF%和 HOMA 是瘦素水平的独立预测因子。在女性中观察到体重指数呈上升趋势,她们的瘦素水平更高,HOMA 水平更低。
肾移植后立即,瘦素和 HOMA 水平下降,至少在 1 年内仍保持降低。移植后 5 年,瘦素、IR、BF%和血脂水平与移植前相似。这种代谢谱可能与移植后期观察到的心血管疾病发生率升高有关。